Sponsored Links

Trifunctional Antibody Catumaxomab Triggers Vaccination Effect Against Cancer PDF Print E-mail
Medical News - GastroIntestinal and Gastroenterology
TRION Pharma GmbH announces today that the results from two different studies demonstrate catumaxomab's capacity to activate the immune system in a way that can otherwise only be achieved through vaccination. The data were obtained by two independent research teams using catumaxomab in malignant ascites and gastric cancer, respectively...

Read more: GastroIntestinal / Gastroenterology News From Medical News Today